Commitment and Motivation in a Brief DBT Intervention for Self Harm
Launched by CENTRE FOR ADDICTION AND MENTAL HEALTH · Feb 2, 2015
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
Client motivation is related to therapeutic change (Ryan, Lynch, Vansteenkiste, \& Deci) and low motivation is a pervasive issue for clients with BPD (e.g., Skodal et al., 1983). DBT (Linehan, 1993) is an effective treatment for BPD and was developed in part to address client motivation. Within DBT there are commitment strategies that are used to help clients establish clear goals and increase motivation to work on them. These strategies were designed to help people commit to eliminating self-harm as well as other behaviours. People are more motivated to work effectively towards goals for w...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Has a valid health card issued by a Canadian province or Canadian student organization (ie: UHIP)
- • 2. Has had at least 3 self-harm episodes (either suicidal or non-suicidal) in the past 5 years, including at least 1 in the past eight weeks
- • 3. Is literate in English
- • 4. Absence of 4 or more formal weeks of DBT in the past year (individual or group therapy components)
- • 5. Indicates absence of knowledge of the DBT Skills
- • 6. Is able to attend all sessions on scheduled study day
- Exclusion Criteria:
- • 1) Evidence of organic brain syndrome or mental retardation
About Centre For Addiction And Mental Health
The Centre for Addiction and Mental Health (CAMH) is Canada’s leading mental health and addiction teaching hospital, dedicated to advancing research, clinical care, and education in the field of mental health. With a commitment to improving the lives of individuals affected by mental illness and addiction, CAMH conducts innovative clinical trials aimed at developing and evaluating new treatment approaches. The institution fosters a collaborative environment that brings together researchers, clinicians, and community partners to translate scientific findings into effective interventions, ensuring the highest standards of care and support for patients. Through its robust research initiatives, CAMH strives to enhance understanding of mental health disorders and promote evidence-based practices in the treatment of addiction and mental health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Michelle Leybman, PhD
Principal Investigator
Centre for Addiction and Mental Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials